Top compounds associated with response to CTD-3105H18.16


Feature Type Standardized
Nominal ANOVA
mRNA quizartinib CTRPv2 pan-cancer AAC 0.084 0.03
mRNA prima-1 CTRPv2 pan-cancer AAC 0.07 0.03
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.078 0.03
mRNA BRD-K34222889 CTRPv2 pan-cancer AAC 0.069 0.03
mRNA BRD-K55473186 CTRPv2 pan-cancer AAC 0.1 0.04
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.078 0.04
mRNA 16-beta-bromoandrosterone CTRPv2 pan-cancer AAC 0.081 0.04
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.078 0.04
mRNA AZD6482 CTRPv2 pan-cancer AAC -0.078 0.04
mRNA ML311 CTRPv2 pan-cancer AAC 0.068 0.05
Download CSV